Casas, R.; Tompa, A.; Ã…kesson, K.; Teixeira, P.F.; Lindqvist, A.; Ludvigsson, J.
Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial. Int. J. Mol. Sci. 2025, 26, 374.
https://doi.org/10.3390/ijms26010374
AMA Style
Casas R, Tompa A, Ã…kesson K, Teixeira PF, Lindqvist A, Ludvigsson J.
Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial. International Journal of Molecular Sciences. 2025; 26(1):374.
https://doi.org/10.3390/ijms26010374
Chicago/Turabian Style
Casas, Rosaura, Andrea Tompa, Karin Ã…kesson, Pedro F. Teixeira, Anton Lindqvist, and Johnny Ludvigsson.
2025. "Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial" International Journal of Molecular Sciences 26, no. 1: 374.
https://doi.org/10.3390/ijms26010374
APA Style
Casas, R., Tompa, A., Ã…kesson, K., Teixeira, P. F., Lindqvist, A., & Ludvigsson, J.
(2025). Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial. International Journal of Molecular Sciences, 26(1), 374.
https://doi.org/10.3390/ijms26010374